# Omentopexy Effect on Gastric Dilatation Post Laparoscopic Sleeve Gastrectomy: A Randomized Controlled Trial

**Authors:** Amir k. Abosayed, Mohamed Ahmed Farahat, Amr Mohammed Abd El Fattah Ayad, Arsany Talaat Saber Wassef, Ahmed Adel Shalaby Alattar, Shady Mohammed Tarek Gamal, Ahmed Yahia Abd EL Dayem

PMC · DOI: 10.1007/s11695-025-08480-6 · Obesity Surgery · 2026-01-27

## TL;DR

This study investigates whether adding omentopexy to gastric sleeve surgery helps prevent stomach dilation and improves long-term weight loss.

## Contribution

The study introduces omentopexy as a novel addition to LSG to reduce postoperative gastric dilation.

## Key findings

- Omentopexy significantly reduced gastric dilation at 6 and 12 months post-surgery.
- There was no significant correlation between gastric volume and weight loss percentages in either group.
- Omentopexy may help stabilize the staple line and prevent recurrent weight gain.

## Abstract

Obesity is a global health crisis. Bariatric surgeries not only induce weight loss but also help in remission of these associated medical problems. Among the various bariatric procedures, laparoscopic sleeve gastrectomy (LSG) has become the most performed procedure worldwide. However, LSG has its own adverse effects. Suboptimal clinical response and recurrent weight gain are among the most challenging sequelae after surgery. Omentopexy is a novel step added to the conventional LSG. Our study aimed to assess the effect of omentopexy on gastric sleeve dilation following LSG and its impact on weight loss after surgery.

This study included 100 patients who were recruited for LSG divided into 2 groups. Patients were randomly enrolled into the non-omentopexy group (underwent LSG without omentopexy) and the omentopexy group (underwent LSG with omentopexy). Gastric volumetry using 3D gastric computed tomography were done for all patients at Day 1, 6 month and 1 year after the operation.

There was no significant difference between the 2 groups at postoperative Day 1 (p = 0.12) regarding the sleeve volumetry. However, after 6 months and 12 months, the non-omentopexy group showed significantly greater volume increase (p < 0.001), there was no significant correlation between gastric sleeve volume and the EWL% and TWL% in Non-omentopexy and Omentopexy groups.

Omentopexy step, although adds more to the operative time, but it may serve as a guard against postoperative sleeve dilation by stabilizing the staple line which can be a major role in maintaining sufficient weight loss and prevents recurrent weight gain on the long term.

LSG has become the most performed bariatric procedure worldwide.

Recurrent weight gain is among the most challenging sequelae after LSG.

Omentopexy fixes the sleeved stomach to the greater omentum.

Omentopexy may stabilize the staple line and prevent postoperative sleeve dilation.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Diseases:** weight gain (MESH:D015430), Weight Loss (MESH:D015431), hiatal hernia (MESH:D006551), Complications (MESH:D008107), weight-loss failure (MESH:D051437), bleeding (MESH:D006470), GERD (MESH:D005764), Obesity (MESH:D009765), dilation (MESH:D002311), leak (MESH:D019559), anastomotic leaks (MESH:D057868)
- **Chemicals:** PDS (MESH:D010165), methylene blue (MESH:D008751), sodium bicarbonate (MESH:D017693), enoxaparin (MESH:D017984), LSG (-), pantoprazole (MESH:D000077402)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13038737/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC13038737/full.md

---
Source: https://tomesphere.com/paper/PMC13038737